Genetic predisposition to leprosy: A major gene reveals novel pathways of immunity to Mycobacterium leprae
- PMID: 16973374
- DOI: 10.1016/j.smim.2006.07.005
Genetic predisposition to leprosy: A major gene reveals novel pathways of immunity to Mycobacterium leprae
Abstract
The elucidation of the genetic control of susceptibility to common infectious diseases is expected to provide new and more effective tools for prevention and control of some of the most pressings health needs on a global scale. A major advantage of whole genome based genetic approaches is that no a priori assumptions about mechanisms of pathogenesis need to be made in these studies. Hence, genetic studies can identify previously unrecognized pathways of disease susceptibility and tag critical pathogenic events for further biochemical, immunological or physiological analysis. We have applied this strategy to leprosy, a disease that still claims 400,000 new cases each year. We identified genetic variants in the shared promoter region of the PARK2 and PACRG genes as major risk factors of leprosy susceptibility. Both encoded proteins are part of the cellular ubiquitination system. Specifically, PARK2, the cause of early onset Parkinson's disease, is an E3 ligase that likely is involved in controlled proteolysis, the cellular anti-oxidants response and the regulation of innate immune responsiveness. In addition, numerous E3 ligases have recently been shown to be critical regulators of immunity. While the specific role of PARK2/PACRG in leprosy pathogenesis remains unknown, a number of experimentally testable scenarios can be developed to further explore the role of these proteins in anti-Mycobacterium leprae host responsiveness.
Similar articles
-
Leprosy as a genetic model for susceptibility to common infectious diseases.Hum Genet. 2008 Apr;123(3):227-35. doi: 10.1007/s00439-008-0474-z. Epub 2008 Feb 5. Hum Genet. 2008. PMID: 18247059 Review.
-
Genetic dissection of immunity in leprosy.Curr Opin Immunol. 2005 Feb;17(1):44-8. doi: 10.1016/j.coi.2004.11.006. Curr Opin Immunol. 2005. PMID: 15653309 Review.
-
Susceptibility to leprosy is associated with PARK2 and PACRG.Nature. 2004 Feb 12;427(6975):636-40. doi: 10.1038/nature02326. Epub 2004 Jan 25. Nature. 2004. PMID: 14737177
-
Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome.Future Microbiol. 2011 May;6(5):533-49. doi: 10.2217/fmb.11.39. Future Microbiol. 2011. PMID: 21585261 Review.
-
Linkage of leprosy susceptibility to Parkinson's disease genes.Int J Lepr Other Mycobact Dis. 2004 Jun;72(2):169-70. doi: 10.1489/1544-581X(2004)072<0169:LOLSTP>2.0.CO;2. Int J Lepr Other Mycobact Dis. 2004. PMID: 15301585
Cited by
-
Mapping of PARK2 and PACRG overlapping regulatory region reveals LD structure and functional variants in association with leprosy in unrelated indian population groups.PLoS Genet. 2013;9(7):e1003578. doi: 10.1371/journal.pgen.1003578. Epub 2013 Jul 4. PLoS Genet. 2013. PMID: 23861666 Free PMC article.
-
PARK2 and proinflammatory/anti-inflammatory cytokine gene interactions contribute to the susceptibility to leprosy: a case-control study of North Indian population.BMJ Open. 2014 Feb 27;4(2):e004239. doi: 10.1136/bmjopen-2013-004239. BMJ Open. 2014. PMID: 24578538 Free PMC article.
-
Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction.PLoS Negl Trop Dis. 2008 May 7;2(5):e231. doi: 10.1371/journal.pntd.0000231. PLoS Negl Trop Dis. 2008. PMID: 18461142 Free PMC article.
-
Human genetics of infectious diseases: between proof of principle and paradigm.J Clin Invest. 2009 Sep;119(9):2506-14. doi: 10.1172/JCI38111. J Clin Invest. 2009. PMID: 19729848 Free PMC article. Review.
-
Leprosy as a genetic model for susceptibility to common infectious diseases.Hum Genet. 2008 Apr;123(3):227-35. doi: 10.1007/s00439-008-0474-z. Epub 2008 Feb 5. Hum Genet. 2008. PMID: 18247059 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical